<PAGE>
---------------------------
OMB APPROVAL
---------------------------
OMB number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response... 14.90
---------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
-----
INTERACTIVE MEDICAL TECHNOLOGIES, LTD.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK $.001 PAR VALUE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
458937109
- --------------------------------------------------------------------------------
(CUSIP Number)
Bruce W. Barren 11099 Sunset Blvd., Los Angeles, CA 90049-3224 (310) 471-3735
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
JANUARY 20, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [_]
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Potential persons who are to respond to the collection of information contained
in this form are set required to respond unless the form displays a currently
valid OMB control number.
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 458937109 SCHEDULE 13D PAGE 2 OF 3 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BRUCE W. BARREN
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
N/A (b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
SOURCE OF FUNDS (SEE INSTRUCTIONS)
4
SC
- ------------------------------------------------------------------------------
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
5 2(d) or 2(e)
N/A
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
U.S. CITIZEN
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 19,500,000
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
19,500,000
- ------------------------------------------------------------------------------
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE
12 INSTRUCTIONS)
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
7.75%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
IN
- ------------------------------------------------------------------------------
Page 2 of 3 pages
<PAGE>
Page 3
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13D
Under the Securities Exchange Act of 1934
Fee enclosed [_] or Amendment No.
Item 1(a) Name of Issuer:
INTERACTIVE MEDICAL TECHNOLOGIES, LTD.
Item 1(b) Address of Issuer's Principal Executive Offices:
2139 Pontius Ave., Los Angeles, CA 90025
Item 2(a) Name of Person(s) Filing:
Bruce W. Barren
Item 2(b) Address of Principal Business Office:
11099 Sunset Blvd., Los Angeles, CA 90049-3224
Item 2(c) Citizenship: U.S. Citizen
Item 2(d) Title of Class of Securities: Common Stock
Item 2(e) CUSIP Number: 458937109
Item 3 The person(s) filing is(are):
(b) [_] Bank as defined in Section 3(a)(6) of the Act.
(e) [_] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940.
(g) [_] Parent Holding Company in accordance with
Section 240.13d-1(b)(1)(ii)(G).
Item 4 Ownership
(a) Amount Beneficially Owned:
See item 9, pg. 2 and 3
(b) Percent of Class: See item 11, pg. 2 and 3
(c) Number of shares as to which such person has:
i) sole power to vote or to direct the vote
See item 5, pg. 2 and 3
ii) shared power to vote or to direct the vote None
iii) sole power to dispose or to direct the disposition of
See item 7, pg. 2 and 3
iv) shared power to dispose or to direct the disposition of
None - beneficial ownership disclaimed pursuant to Rule 13d-4
Item 5 Ownership of 5% or Less of a Class: N/A
Item 6 Ownership of More than 5% on Behalf of Another Person: N/A
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
(1) Capital Research and Management Company is an Investment Adviser
registered under Section 203 of the Investment Advisers Act of
1940 and is a wholly owned subsidiary of The Capital Group, Inc.
(2) Capital Guardian Trust company is a Bank as defined in Section 3(a)(6)
of the Act and a wholly owned subsidiary of The Capital Group, Inc.
(3) Capital International S.A. (CISA) does not fall within any of the
categories described in Rule 13d-1(b)(ii)(A-F) but its holdings of any
reported securities come within the five percent limitations as set
forth in a December 15, 1986 no-action letter from the Staff of the
Securities and Exchange Commission to The Capital Group, Inc. CISA is
a wholly owned subsidiary of The Capital Group, Inc.
(4) Capital International Limited (CIL), does not fall within any of the
categories described in Rule 13d-1(b)(ii)(A-F) but its holding of any
reported securities come within the five percent limitation as set
forth in a December 15, 1986 no-action letter from the Staff of the
Securities and Exchanged Commission to The Capital Group, Inc. CIL is
a wholly owned subsidiary of The Capital Group, Inc.
(5) Capital International Research and Management, Inc. dba Capital
International, Inc. is an investment Adviser registered under Section
203 of the Investment advisers Act of 1940 and is a wholly owned
subsidiary of The Capital Group, Inc.
Item 8 Identification and Classification of Members of the Group: N/A
Item 9 Notice of Dissolution of the Group: N/A
Item 10 Certification
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 3, 1998
Signature: /s/ Bruce Barren
----------------------------------------------
Name/Title:
----------------------------------------------
-----------------------------------------------